Rare diseases
Investigational molecules
Locations
Back to Germany2 clinical trials in Marktredwitz, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)GermanyGermanyThe busiest research cities in the country
What the registry says about research in the country
Clinical research focusing on advanced breast cancer treatment, specifically targeting patients with HER2-negative and hormone receptor-positive characteristics. The studies aim to analyze therapeutic responses and survival outcomes.
This comprehensive investigation examines spatial and temporal patterns in treatment efficacy, providing valuable insights into breast cancer therapy resistance mechanisms.
Advanced research exploring treatment effectiveness patterns in first-line therapeutic settings. The studies evaluate comprehensive molecular responses to targeted therapies.
The research aims to enhance understanding of treatment outcomes through detailed monitoring of patient responses over time.
Focused investigation of patient survival metrics in advanced breast cancer treatment, analyzing both short-term and long-term outcomes in response to targeted therapies.
The research provides crucial data on survival rates and treatment effectiveness in advanced breast cancer cases.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
